Advanced search
Publication Cover
Future Science OA Volume 6, 2020 - Issue 8
Submit an article Journal homepage
13,657
Views
32
CrossRef citations to date
0
Altmetric
Editorial

Cannabis for COVID-19: Can Cannabinoids Quell the Cytokine Storm?

Emmanuel Shan Onaivi1 Department of Biology, College of Science & Health, William Paterson University, Wayne, NJ, 07470, USA;2 College of Science & Health, William Paterson University, Wayne, NJ, 07470, USACorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0002-7561-8927
ORCID Icon &
Venkatanarayanan Sharma1 Department of Biology, College of Science & Health, William Paterson University, Wayne, NJ, 07470, USA;2 College of Science & Health, William Paterson University, Wayne, NJ, 07470, USA
Article: FSO625 | Received 12 Jul 2020, Accepted 27 Jul 2020, Published online: 13 Aug 2020

References

  • HsiangS , AllenD , Annan-PhanSet al.The effect of large-scale anti-contagion policies on the COVID-19 pandemic. Nature https://doi.org/10.1038/s41586-020-2404-8 (2020) ( Epub ahead of print).
  • MaguireG. Better preventing and mitigating the effects of Covid-19. Future Sci. OA6(1), FSO586 (2020).
  • DengX , GuW , FedermanSet al.Genomic surveillance reveal multiple introduction of SARS-CoV-2 into Northern California. Science doi:10.1126/science.abb9263 (2020) ( Epub ahead of print).
  • GuoYR , CaoQD , HongZSet al.The origin, transmission and clinical therapies on coronavirus disease 2019 (COVID-19) outbreak – an update on the status. Mil Med Res. doi:10.1186/s40779-020-00240-0 (2020) ( Epub ahead of print).
  • World Health Organization. Coronavirus disease (COVID-19). Surveillance strategies for COVID-19 human infection. Situation Report161, 1–16 (2020).
  • SharmaV. Current perspectives on cytokines for anti-retroviral therapy in AIDS related B-cell lymphomas. Curr. Drug Targets Infect. Disord.3, 137–149 (2003).
  • RizzoMD , HenriquezJE , BlevinsLK , BachA , CrawfordRB , KaminskiNE. Targeting cannabinoid receptor 2 on peripheral leukocytes to attenuate inflammatory mechanisms implicated in HIV-associated neurocognitive disorder. J. Neuroimmune Pharmacol. Doi: 10.1007/s11481-020-09918-7 (2020) ( Epub ahead of print).
  • CostiniukCT , JenabianMA. Acute inflammation and pathogenesis of SAR-CoV-2 infection: cannabidiol as a potential anti-inflammatory treatment. Cytokine Growth Factor Rev.53, 63–65 (2020).
  • RossiF , TortoraC , ArgenzianoM , DiPaola A , PunzoF. Cannabinoid receptor type 2: a possible target in SAR-CoV-2 (CoV-19) infection?Int. J. Mol. Sci.21(11), E3809. doi:10.3390/ijms21113809 (2020) ( Epub ahead of print).
  • OnaiviES , ChauhanBPS , SharmaV. Challenges of cannabinoid delivery: how can nanomedicine help?Nanomedicine (Lond). Doi: 10.2217/nnm-2020-0221 (2020) ( Epub ahead of print).
  • JoshiN , OnaiviES. Endocannabinoid system components: overview and tissue distribution. In: Recent Advances in Cannabinoid Physiology and Pathology. Bukiya ( Ed.). Adv. Exp. Med. Biol. 1162, Springer Nature, Switzerland, 1–12 (2019).
  • OlahA , SzekaneczZ , BiroT. Targeting cannabinoid signaling in the immune system: “High”-ly exciting questions, possibilities, and challenges. Front Immunol.8, 1487 (2017).
  • WalterL , StellaN. Cannabinoids and neuroinflammation. Br. J. Pharmacol.141, 775–785 (2008).
  • Almogi-HazanO , OrR. Cannabis, the endocannabinoid system and immunity – the journey from bedside to the bench and back. Int. J. Mol. Sci.21(12), E448 (2020).
  • LongQ , TangX , ShiQet al.Asymptomatic people with SARS-CoV-2 may have weaker immune response to virus. Nature Med. https://doi.org/10.1038/s41591-020-0965-6 (2020) ( Epub ahead of print).
  • EllinghausD , DegenhardtF , BujandaLet al.Genomewide association study of severe COVID-19 with respiratory failure. N Engl. J. Med. Doi: 10.1056/NEJMoa2020283 (2020) ( Epub ahead of print).
  • SaghazadehA , RezaeiN. Towards treatment planning of COVID-19: rationale and hypothesis for the use of multiple immunosuppressive agents: anti-antibodies, immunoglobulins, and corticosteroids. Int. Immunopharmacol.84, 106560 (2020).
  • ElhusseinyKM , Abd-ElhayFA , KamelMG. Possible therapeutic agents for COVID-19: a comprehensive review. Expert Rev. Anti Infect. Ther.30, 1–15 (2020).
  • BonafeM , PrattichizzoF , GianlucaA , StorciG , SabbatinelliJ , OlivieriF. Inflamm-aging: why older men are the most susceptible to SARS-CoV-2 complicated outcomes. Cytokine Growth Factor Rev.53, 33–37 (2020).
  • WuY , FengZ , LiaP , YuaQ. Relation between ABO blood group distribution and clinical characteristics in patients with COVID-19. Clin. Chim. Acta509, 220–223 (2020).
  • VabretN , BrittonGJ , GruberCet al.Immunology of COVID-19: current state of the Science. Immunity52(6), 910–941 (2020).
  • TahamtanA , Tavakoli-YarakiM , SalimiV. Opioids/cannabinoids as potential therapeutic approach in COVID-19 patients. Expert Rev. Resp. Med. Doi: 10.1080/17476348.2020.1787836 (2020) ( Epub ahead of print).
  • ShiauS , KrauseKD , ValeraP , SwaminathanS , HalkitisPN. The burden of COVID-19 in people living with HIV: a syndemic perspective. AIDS Behav.18, 1–6 (2020).
  • TarasovaO , IvanovS , FilimonovDA , PoroikovV. Data text mining help identify key proteins involved in the molecular mechanisms shared by SARS-CoV-2 and HIV-1. Molecules25(12), E2944 (2020).
  • MamberSW , KrawkowkaS , OsbornJet al.Can unconventional immunomodulatory agents help alleviate COVID-19 symptoms and severity?mSphere5(3), e00288–20 (2020).

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.